Pipeline Noticeocds-h6vhtk-04f703

NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025

Provision of Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; • neovascular (wet) age-related macular degeneration (AMD) • visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) • proliferative diabe...

Buyer

NHS England

Value

£1,516,353,164

Published

21 Mar 2025

Closes

21 Mar 2025

Procurement details

Source

Find a Tender

Region

Lambeth

Procurement method

Not provided

Category

Goods

Contract starts

Not provided

Contract ends

Not provided

CPV classifications

33600000

Pharmaceutical products

33690000

Various medicinal products

Lots

Lot 1 NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025

Value not provided

Delivery: UK · United Kingdom

Preliminary market engagement notice on Find a Tender

21 Mar 2025

Preliminary market engagement notice on Find a Tender

Market engagement notice · UK2 · Web page

Contains public sector information licensed under the Open Government Licence v3.0.